Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
- PMID: 28443567
- PMCID: PMC5450862
- DOI: 10.4274/balkanmedj.2016.1114
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
Abstract
Background: Cardiovascular diseases are an important cause of morbidity and mortality in chronic obstructive pulmonary disease patients. The increased inflammatory biomarker levels predict exacerbations and are associated with cardiovascular diseases in stable chronic obstructive pulmonary disease patients but their role in the settings of acute chronic obstructive pulmonary disease exacerbations has not been determined.
Aims: To analyse the association between inflammatory biomarkers and heart failure and also to determine the predictors of mortality in patients with exacerbations of chronic obstructive pulmonary disease.
Study design: Prospective observational study.
Methods: We analysed 194 patients admitted for acute exacerbation of chronic obstructive pulmonary disease at The Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia. In all patients, C-reactive protein, fibrinogen, N-terminal of the pro-hormone brain natriuretic peptide and white blood count were measured and transthoracic echocardiography was performed.
Results: There were 119 men (61.3%) and the median age was 69 years (interquartile range 62-74). Left ventricular systolic dysfunction (ejection fraction <50%) was present in 47 (24.2%) subjects. Patients with left ventricular systolic dysfunction had higher C-reactive protein levels (median 100 vs. 31 mg/L, p=0.001) and fibrinogen (median 5 vs. 4 g/L, p=<0.001) compared to those with preserved ejection fraction. The overall hospital mortality was 8.2% (16/178). The levels of C-reactive protein, fibrinogen, N-terminal pro-brain natriuretic peptide and ejection fraction predicted hospital mortality in univariate analysis. After adjusting for age, hypoxemia and C-reactive protein, ejection fraction remained significant predictors of hospital mortality (OR 3.89, 95% CI 1.05-15.8).
Conclusion: Nearly a quarter of patients with the exacerbation of chronic obstructive pulmonary disease present with left ventricular systolic dysfunction which may be associated with mortality.
Keywords: Chronic obstructive pulmonary disease; inflammatory biomarkers heart failure..
Conflict of interest statement
Figures
Similar articles
-
Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?Balkan Med J. 2018 Nov 15;35(6):422-426. doi: 10.4274/balkanmedj.2018.0006. Epub 2018 Jul 3. Balkan Med J. 2018. PMID: 29966999 Free PMC article.
-
N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).Lung. 2018 Oct;196(5):583-590. doi: 10.1007/s00408-018-0137-3. Epub 2018 Jun 27. Lung. 2018. PMID: 29951921
-
N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.Respirology. 2012 May;17(4):660-6. doi: 10.1111/j.1440-1843.2012.02153.x. Respirology. 2012. PMID: 22348741
-
Misdiagnosis of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus in Primary Care: A Report of Two Cases and Literature Review.Vasc Health Risk Manag. 2024 Nov 3;20:479-485. doi: 10.2147/VHRM.S489882. eCollection 2024. Vasc Health Risk Manag. 2024. PMID: 39512547 Free PMC article. Review.
-
Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.Thorax. 2013 Jul;68(7):670-6. doi: 10.1136/thoraxjnl-2012-201871. Epub 2012 Jun 28. Thorax. 2013. PMID: 22744884 Free PMC article. Review.
Cited by
-
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics.Clin Sci (Lond). 2022 Mar 31;136(6):405-423. doi: 10.1042/CS20210835. Clin Sci (Lond). 2022. PMID: 35319068 Free PMC article. Review.
-
Relationship between Severity of Chronic Obstructive Pulmonary Disease and Left Ventricular Diastolic Dysfunction.Tanaffos. 2024 Mar;23(3):294-299. Tanaffos. 2024. PMID: 40704342 Free PMC article.
-
Plasma Histone H4 and Its Implications in the Setting of Sepsis-related Myocardial Dysfunction.Balkan Med J. 2020 Apr 10;37(3):119-120. doi: 10.4274/balkanmedj.galenos.2020.2019.12.144. Epub 2020 Jan 30. Balkan Med J. 2020. PMID: 31999080 Free PMC article. No abstract available.
-
NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.Int J Chron Obstruct Pulmon Dis. 2023 May 10;18:811-825. doi: 10.2147/COPD.S396663. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37197601 Free PMC article.
-
Real-time experience of an acute exacerbation of COPD: A qualitative exploration.Chron Respir Dis. 2025 Jan-Dec;22:14799731251340407. doi: 10.1177/14799731251340407. Epub 2025 May 13. Chron Respir Dis. 2025. PMID: 40359900 Free PMC article.
References
-
- Global initiative for chronic Obstructive Lung Disease. 2015 Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease. [Internet] Available at website: www.goldcopd.org/guidelines-global-strategy-for-di... . - PubMed
-
- Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65. - PubMed
-
- Halpern MT, Stanford RH, Borker R. The burden of COPD in the U.S.A: results from the confronting COPD survey. Respir Med. 2003;97(Suppl C):81–9. - PubMed
-
- Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, et al. Inflamatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013;309:2353–61. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials